Newsletter
Helping Clients/Patients Meet Targets with GLP-1 and GIP/GLP-1 Receptor Agonists with Christie Schumacher

The Huddle: Conversations with the Diabetes Care Team

Helping Clients/Patients Meet Targets with GLP-1 and GIP/GLP-1 Receptor Agonists with Christie Schumacher

November 16, 2022

Helping Clients/Patients Meet Targets with GLP-1 and GIP/GLP-1 Receptor Agonists with Christie Schumacher

Christie Schumacher PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP, joins The Huddle to talk through the use of GLP-1 and GIP/GLP-1 receptor agonists for your people with type 2 diabetes.  You’ll learn what medications fall into the class of GLP-1 and GIP/GLP-1 receptor agonists, how they work and the benefits they can offer people with type 2 diabetes. These medications can be a useful tool in the therapeutic toolkit as highlighted in the recently updated ADA/EASD consensus statement, so this episode will offer practical considerations when initiating GLP-1 and GIP/GLP-1 receptor agonists in patients and managing possible side effects.

We want to thank our sponsor, Lilly Diabetes, for their support of this episode.
VV-MED-128766 ©2022 Lilly USA, LLC.  All rights reserved

Resources:

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
How To… DIY Climate Action So you want to start infusing climate best practices into your workflow and ensure climate becomes a part of your protocol or criteria – but how?!